Nura
Development stage biotechnology company focused on the discovery of therapeutics for behavioral disorders.
Launch date
Market cap
-
Enterprise valuation
€35—52m (Dealroom.co estimates Sep 2004.)
Seattle Washington (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$9.5m | Series A | ||
N/A | Acquisition | ||
N/A | Seed | ||
| Total Funding | €8.6m | ||